Onyx Bridge Wealth Group »

Aslan Pharmaceuticals shares owned by Onyx Bridge Wealth Group

Quarter-by-quarter ownership of Aslan Pharmaceuticals (ASLN) shares owned by Onyx Bridge Wealth Group from 13F filings

Historical chart of Onyx Bridge Wealth Group investment in Aslan Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aslan Pharmaceuticals held by Onyx Bridge Wealth Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aslan Pharmaceuticals by Onyx Bridge Wealth Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.4k 23k 0.42
2023-12-31 $12k 23k 0.52

More positions owned by Onyx Bridge Wealth Group

Ishares Tr Core S&p500 Etf (IVV)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Short Treas Bd (SHV)
Apple (AAPL)
Vanguard Specialized Funds Div App Etf (VIG)
Select Sector Spdr Tr Technology (XLK)
Select Sector Spdr Tr Financial (XLF)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Select Sector Spdr Tr Communication (XLC)
Select Sector Spdr Tr Energy (XLE)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Onyx Bridge Wealth Group

Top funds holding Aslan Pharmaceuticals

BVF
UBS Group
Citadel Advisors
Shay Capital
Millennium Management
FNY Investment Advisers
Waterfront Wealth
Ikarian Capital
Schonfeld Strategic Advisors
Jane Street
Onyx Bridge Wealth Group
Capital Analysts
Rhumbline Advisers
Cutler

View all funds holding Aslan Pharmaceuticals